IMMEDIATE RELEASE 26 March 2024
A.G. BARR p.l.c.
("A.G. BARR" or the "Company")
A.G. BARR is a branded multi-beverage business with a portfolio of market-leading UK brands, including IRN-BRU, Rubicon, FUNKIN and Boost.
Directorate changes announcement
The Board of Directors (Board) of A.G. BARR p.l.c. announces that Jonathan Kemp has advised the Board that, owing to family health reasons, he will not seek re-election as a statutory director of the Company at its Annual General Meeting scheduled to take place on 31 May 2024 (AGM) and will retire as a director of the Company following conclusion of the AGM. In order to facilitate a smooth leadership transition, Jonathan will continue to lead the Commercial function until 30 September 2024. Thereafter he will remain available to the Company as required for a further twelve month period following which he will retire from the business. The business will commence a recruitment process in due course to identify a successor - this role will not be an executive director Board position.
As previously communicated on 26 May 2023, after nine years as a Non-Executive Director, David Ritchie will stand down from the Board with effect from the conclusion of the AGM. David will be succeeded by Louise Smalley as Remuneration Committee Chair.
Mark Allen, Chair of A.G. BARR, commented "On behalf of the Board, I would like to thank Jonathan for his significant contribution to A.G. BARR for over 20 years. As Commercial Director, he has been instrumental to the growth of the Company, with the business in a strong position to continue to grow and develop. We wish him and his family all the very best for the future. I would also like to thank David for his commitment and contribution to the business over many years. The Board has benefitted from his extensive knowledge and experience and wishes him well with his future endeavours."
For more information, please contact:
|
A.G. BARR 0330 390 3900 Mark Allen, Chair |
Instinctif Partners 020 7457 2020 Justine Warren Matthew Smallwood |
|
|
|
|
|
|
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
